Hematology / cITP

Use of Splenectomy in the Treatment of Chronic Immune Thrombocytopenia

expert roundtables by Adam Cuker, MD, MS, Terry Gernsheimer, MD, Howard A. Liebman, MD

The use of splenectomy has declined in recent years with the introduction of additional medications for the treatment of patients with immune throm......READ MORE

cITP

Biological and Clinical Predictive Factors of Response in Patients With Chronic Immune Thrombocytopenia

expert roundtables by Adam Cuker, MD, MS, Terry Gernsheimer, MD, Howard A. Liebman, MD

cITP

Choosing Between Thrombopoietin Receptor Agonists as Second-line Therapy in Chronic Immune Thrombocytopenia

expert roundtables by Adam Cuker, MD, MS, Terry Gernsheimer, MD, Howard A. Liebman, MD

cITP

Mechanisms Contributing to the Pathophysiology of Immune Thrombocytopenia

expert roundtables by Adam Cuker, MD, MS, Terry Gernsheimer, MD, Howard A. Liebman, MD

LATEST IN Hematology

cITP

Treatment of Refractory Immune Thrombocytopenia

expert roundtables by Adam Cuker, MD, MS, Terry Gernsheimer, MD, Howard A. Liebman, MD

Immune thrombocytopenia (ITP) is often chronic and refractory to treatment. A chart review of patients with treatment-refractory chronic ITP who we......READ MORE

cITP

Clinical Trials in Immune Thrombocytopenia

expert roundtables by Adam Cuker, MD, MS, Terry Gernsheimer, MD, Howard A. Liebman, MD

New therapies and treatment recommendations for chronic immune thrombocytopenia (ITP) have emerged in the last decade, including the thrombopoietin......READ MORE

Browse More Articles